We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $646M
1-Year Est. Return 43.3%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+43.3%
3 Year Est. Return
+98.62%
5 Year Est. Return
+125.42%
10 Year Est. Return
+408.39%
AUM
$236M
AUM Growth
+$11.3M
Cap. Flow
+$2.4M
Cap. Flow %
1.02%
Top 10 Hldgs %
32.76%
Holding
119
New
6
Increased
45
Reduced
36
Closed
15

Top Buys

Rank Stock Value
1
CDK
CDK Global, Inc.
CDK
+$916K
2
ABT icon
Abbott
ABT
+$605K
3
ROK icon
Rockwell Automation
ROK
+$566K
4
XLNX
Xilinx Inc
XLNX
+$559K
5
TGT icon
Target
TGT
+$520K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$2.61M
2
ADP icon
Automatic Data Processing
ADP
+$553K
3
XOM icon
ExxonMobil
XOM
+$394K
4
DYAX
DYAX CORPORATION
DYAX
+$376K
5
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$354K

Sector Composition

Rank Sector Weight
1 Technology 21.07%
2 Healthcare 20.68%
3 Industrials 19.38%
4 Energy 10.99%
5 Consumer Staples 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
51
IBM
IBM
$223B
$1.09M 0.46%
7,107
-188
-3% -$29.9K
CDK
52
DELISTED
CDK Global, Inc.
CDK
$1.05M 0.45%
+25,869
New +$916K
IONS icon
53
Ionis Pharmaceuticals
IONS
$9.39B
$967K 0.41%
15,657
+1,048
+7% +$51.7K
DYAX
54
DELISTED
DYAX CORPORATION
DYAX
$901K 0.38%
64,100
-30,000
-32% -$376K
COP icon
55
ConocoPhillips
COP
$150B
$848K 0.36%
12,265
– –
ILMN icon
56
Illumina
ILMN
$29.1B
$788K 0.33%
4,388
+243
+6% +$42.8K
CI icon
57
Cigna
CI
$73.5B
$621K 0.26%
6,030
-450
-7% -$44.3K
TT icon
58
Trane Technologies
TT
$105B
$591K 0.25%
9,326
-241
-3% -$14.7K
MCD icon
59
McDonald's
MCD
$193B
$555K 0.24%
5,920
-355
-6% -$33.2K
CVE icon
60
Cenovus Energy
CVE
$56.4B
$546K 0.23%
26,494
-7,282
-22% -$168K
GSK icon
61
GSK
GSK
$101B
$518K 0.22%
9,682
-46,708
-83% -$2.61M
PFE icon
62
Pfizer
PFE
$153B
$515K 0.22%
17,423
-1,009
-5% -$28.9K
KMB icon
63
Kimberly-Clark
KMB
$36.8B
$466K 0.2%
4,030
-403
-9% -$44.7K
ALNY icon
64
Alnylam Pharmaceuticals
ALNY
$30.4B
$457K 0.19%
4,702
-151
-3% -$14K
CYN
65
DELISTED
CITY NATIONAL CORPORATION
CYN
$457K 0.19%
+5,660
New +$437K
PSX icon
66
Phillips 66
PSX
$92.8B
$433K 0.18%
6,036
-124
-2% -$9.15K
NEE icon
67
NextEra Energy
NEE
$179B
$430K 0.18%
16,160
-672
-4% -$17K
CSX icon
68
CSX Corp
CSX
$92.8B
$424K 0.18%
35,100
– –
BAX icon
69
Baxter International
BAX
$14B
$399K 0.17%
10,011
-89
-0.9% -$3.47K
STT icon
70
State Street
STT
$52.2B
$398K 0.17%
5,068
– –
TMO icon
71
Thermo Fisher Scientific
TMO
$223B
$352K 0.15%
2,803
– –
LLY icon
72
Eli Lilly
LLY
$1.08T
$317K 0.13%
4,600
-282
-6% -$19K
GIS icon
73
General Mills
GIS
$20.8B
$315K 0.13%
5,900
-304
-5% -$15.7K
WMT icon
74
Walmart Inc
WMT
$921B
$315K 0.13%
11,010
-3,645
-25% -$98.5K
NGG icon
75
National Grid
NGG
$81.6B
$295K 0.13%
4,328
+311
+8% +$21.6K
1 2
3
4 5

Similar funds

HCM
Huber Capital Management El Segundo, California $647M AUM 24.91% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
CRCM
Cat Rock Capital Management Greenwich, Connecticut $644M AUM 1.97% 1-Year Est. Return
GECH
Garnet Equity Capital Holdings New York $642M AUM 58.94% 1-Year Est. Return
APC
Alta Park Capital San Francisco, California $642M AUM 140.04% 1-Year Est. Return
WHGAM
Wealth High Governance Asset Management Sao Paulo $641M AUM
AG
Alibaba Group Causeway Bay, Hong Kong $653M AUM 16.11% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Brian C. Broderick's Q4 2014 Portfolio in Review

As of Q4 2014, Brian C. Broderick held 119 positions worth $236M, up 5% from $225M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Brian C. Broderick's Q4 2014 filing shows 6 new, 45 increased, 36 reduced and 15 closed positions. Its largest new stake was CDK Global, Inc.: 25,869 shares worth $1.05M. The largest sale was GSK, an estimated $2.61M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Brian C. Broderick's largest Q4 2014 buy was CDK Global, Inc.: 25,869 shares worth $1.05M.
  • Brian C. Broderick added most to Abbott in Q4 2014, an estimated $605K increase.
  • Brian C. Broderick's biggest Q4 2014 reduction was GSK, cutting an estimated $2.61M.
  • Brian C. Broderick fully exited Vanguard FTSE Emerging Markets ETF in Q4 2014, selling an estimated $354K.
  • Brian C. Broderick's ten largest holdings make up 33% of its $236M portfolio in Q4 2014.
  • Brian C. Broderick opened 6 new positions and closed 15 in Q4 2014.
  • Brian C. Broderick's portfolio value rose 5% quarter-over-quarter to $236M.

Based on Brian C. Broderick's 13F filing for Q4 2014, filed 13 Feb 2015.